The research covered in this report showed that genetic ablation of CYP1A1 contributes to intestinal barrier protection against MRSA-induced sepsis by shifting the microbiota composition to decrease cadaverine metabolite levels in a non-AHR-dependent manner. Here, AHR is linked to Sepsis.